Race Oncology Limited
RAONF
Price:
$2.6
Market Cap:
$475.21M
Based in Sydney, Australia, Race Oncology Limited is an Australian precision oncology firm that commenced operations in 2011. The company's primary focus is the development of Zantrene, a potent small molecule designed to inhibit the fatso/fat mass and obesity associated protein (FTO). This therapeutic agent is currently in Phase II/III clinical trials, exploring its potential to treat a range of cancers, including melanoma, clear cell renal cell carcinoma, acute myeloid leukaemia, breast cancer, and ovarian cancer. Race Oncology actively pursues preclinical research through a program with the University of Newcastle to investigate Zantrene further, and maintains a strategic partnership with...[Read more]
Industry
Biotechnology
IPO Date
2021-03-09
Stock Exchange
OTC
Ticker
RAONF
PE Ratio
[-43.33]
ROE
[-47.44%]
Current Ratio
[18.37]
Dividend Yield
[0%]
Enterprise Value
[454.27M]
Dividend History
The ROE as of June 2026 (TTM) for Race Oncology Limited (RAONF) is -47.44%
According to Race Oncology Limited’s latest financial reports and current stock price. The company's current ROE is -47.44%. This represents a change of 105.05% compared to the average of -23.14% of the last 4 quarters.
Race Oncology Limited (RAONF) Historical ROE (quarterly & annually)
How has RAONF ROE performed in the past?
The mean historical ROE of Race Oncology Limited over the last ten years is -52.29%. The current -47.44% ROE has changed -9.28% with respect to the historical average. Over the past ten years (40 quarters), RAONF's ROE was at its highest in in the December 2015 quarter at 205.81%. The ROE was at its lowest in in the June 2015 quarter at -1420.84%.
Average
-52.29%
Median
-56.90%
Minimum
-79.51%
Maximum
-7.80%
Race Oncology Limited (RAONF) ROE by Quarter and Year
Discovering the peaks and valleys of Race Oncology Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 849.04%
Maximum Annual ROE = -7.80%
Minimum Annual Increase = -99.49%
Minimum Annual ROE = -79.51%
| Year | ROE | Change |
|---|---|---|
| 2025 | -29.90% | -60.38% |
| 2024 | -75.46% | 93.82% |
| 2023 | -38.93% | 25.50% |
| 2022 | -31.02% | -32.85% |
| 2021 | -46.20% | -31.65% |
| 2020 | -67.59% | -6.71% |
| 2019 | -72.46% | -8.88% |
| 2018 | -79.51% | 7.44% |
| 2017 | -74.01% | 849.04% |
| 2016 | -7.80% | -99.49% |
Race Oncology Limited (RAONF) Average ROE
How has RAONF ROE performed in the past?
The current ROE of Race Oncology Limited (RAONF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-48.10%
5-year avg
-44.30%
10-year avg
-52.29%
Race Oncology Limited (RAONF) ROE vs. Peers
How is RAONF’s ROE compared to its peers?
Race Oncology Limited’s ROE is greater than BioInvent International AB (publ) (-53.88%), less than MedinCell S.A. (84.89%), greater than Avacta Group Plc (-2929.47%), greater than PureTech Health plc (-31.98%), greater than Healios K.K. (-75.40%), less than GenSight Biologics S.A. (42.20%), less than Northwest Biotherapeutics, Inc. (62.41%), less than Clinuvel Pharmaceuticals Limited (13.29%), greater than Verano Holdings Corp. (-33.23%), greater than Nxera Pharma Co., Ltd. (-15.58%),
| Company | ROE | Market cap |
|---|---|---|
| -53.88% | $216.40M | |
| 84.89% | $1.23B | |
| -2929.47% | $454.97M | |
| -31.98% | $413.81M | |
| -75.40% | $193.79M | |
| 42.20% | $30.99M | |
| 62.41% | $312.23M | |
| 13.29% | $348.84M | |
| -33.23% | $470.36M | |
| -15.58% | $567.36M |
Build a custom stock screener for Race Oncology Limited (RAONF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Race Oncology Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Race Oncology Limited (RAONF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Race Oncology Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Race Oncology Limited's ROE?
How is the ROE calculated for Race Oncology Limited (RAONF)?
What is the highest ROE for Race Oncology Limited (RAONF)?
What is the 3-year average ROE for Race Oncology Limited (RAONF)?
What is the 5-year average ROE for Race Oncology Limited (RAONF)?
How does the current ROE for Race Oncology Limited (RAONF) compare to its historical average?